Results 111 to 120 of about 10,352 (144)

The new insights of lactate in various kidney diseases. [PDF]

Expert Rev Mol Med
Guan K, Zhang Y, Guo S, Ning X, Sun S.
europepmc   +1 more source

The metabolic escape: how tumor metabolic reprogramming drives drug resistance. [PDF]

PeerJ
Chen Y, Wu Z, Si W, Liu X.
europepmc   +1 more source

Obesity-derived metabolites modulate anti-tumor immunity in the tumor microenvironment: from mechanisms to clinical applications. [PDF]

BMC Med
Cai Y, Jin J, Wang Y, Han D, Yu X, Jin F, Li M, Li Y, Li X.   +8 more
europepmc   +1 more source

Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons. [PDF]

Front Immunol
Yang Q, Yang Z, Zhao H.
europepmc   +1 more source

Administration of ketogenic intervention as a potential treatment during post-traumatic brain injury recovery: a scoping review. [PDF]

Front Nutr
Quddus DY, Aydin S, Waheed AA, Zeeshan Q, Hamilton DK, Agarwal N, Maroon JC.   +6 more
europepmc   +1 more source

Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma. [PDF]

Oncogenesis
Neumann MA, Frezza C.
europepmc   +1 more source

Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4. [PDF]

Ther Adv Med Oncol
Mangani K, Pantazaka E, Lianidou E, Georgoulias V, Kotsakis A, Markou A, Kallergi G.   +6 more
europepmc   +1 more source

Lactate metabolic reprogramming and lactylation modification: molecular mechanisms reshaping the tumor immunosuppressive microenvironment. [PDF]

Cell Biosci
Yuan Y, Gao Y, Xue J, Zhang H, Liang R, Huang L, Wang Z, Song L, Qin Y, Ai J.   +9 more
europepmc   +1 more source

Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology. [PDF]

Front Microbiol
Cui Y, Sun W, Wei L, Fan S, Li Q, Duan L.   +5 more
europepmc   +1 more source